Your browser doesn't support javascript.
loading
KMT2A-CBL rearrangements in acute leukemias: clinical characteristics and genetic breakpoints.
Bataller, Alex; Guijarro, Francesca; Caye-Eude, Aurélie; Strullu, Marion; Sterin, Arthur; Molina, Oscar; Chevallier, Patrice; Zaliova, Marketa; Zuna, Jan; Mozas, Pablo; Magnano, Laura; Grardel, Nathalie; Cornillet-Lefebvre, Pascale; Fu, Jen-Fen; Shih, Lee-Yung; Boneva, Temenuzhka; Nacheva, Elisabeth; Beà, Silvia; López-Guerra, Mònica; Bueno, Clara; Menéndez, Pablo; Esteve, Jordi; Larghero, Patrizia; Meyer, Claus; Marschalek, Rolf.
Afiliação
  • Bataller A; Hematology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS).
  • Guijarro F; Josep Carreras Leukemia Research Institute, School of Medicine.
  • Caye-Eude A; Hematopathology Section, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Strullu M; Department of Genetics and Molecular Genetics.
  • Sterin A; Department of Pediatric Hematology, AP-HP, Robert Debré Hospital, Paris, France.
  • Molina O; Department of Pediatric Hematology, Immunology and Oncology, APHM, La Timone Children Hospital, Marseille, France.
  • Chevallier P; Josep Carreras Leukemia Research Institute, School of Medicine.
  • Zaliova M; Hematology Department, CHU Hotel-Dieu, Nantes, France.
  • Zuna J; CLIP, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University Prague and University Hospital Motol, Prague, Czech Republic.
  • Mozas P; CLIP, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University Prague and University Hospital Motol, Prague, Czech Republic.
  • Magnano L; Hematology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS).
  • Grardel N; Hematology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS).
  • Cornillet-Lefebvre P; Department of Hematology, University Hospital Claude Huriez, Lille, France.
  • Fu JF; Laboratoire d'Hématologie, Hôpital Robert Debré, Reims, France.
  • Shih LY; Department of Medical Research, Chang Gung Memorial Hospital-Linkou, Taoyuan, Taiwan.
  • Boneva T; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Taipei, Taiwan.
  • Nacheva E; HSL Analytics LLP OncoGenomics, London, United Kingdom and UCL Cancer Institute, UK.
  • Beà S; HSL Analytics LLP OncoGenomics, London, United Kingdom and UCL Cancer Institute, UK.
  • López-Guerra M; Hematopathology Section, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Bueno C; Centro de Investigación Biomédica en Red de Cáncer.
  • Menéndez P; Hematopathology Section, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Esteve J; Centro de Investigación Biomédica en Red de Cáncer.
  • Larghero P; Josep Carreras Leukemia Research Institute, School of Medicine.
  • Meyer C; Centro de Investigación Biomédica en Red de Cáncer.
  • Marschalek R; RICORS-TERAV, ISCIII, Madrid, Spain.
Blood Adv ; 5(24): 5617-5620, 2021 12 28.
Article em En | MEDLINE | ID: mdl-34638131

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia / Proteína de Leucina Linfoide-Mieloide Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia / Proteína de Leucina Linfoide-Mieloide Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article